IndexIQ Advisors’s Aerie Pharmaceuticals AERI Stock Holding History

IndexIQ Advisors’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$383K	Buy	+42,041	New	+$324K	0.01%	890
2021 Q1	–	Sell	-15,515	Closed	-$210K	–	1365
2020 Q4	$210K	Buy	15,515 +1,602	+12%	+$19.4K	0.01%	897
2020 Q3	$164K	Buy	13,913 +756	+6%	+$9.21K	0.01%	796
2020 Q2	$194K	Sell	13,157 -711	-5%	-$10.5K	0.01%	614
2020 Q1	$187K	Buy	+13,868	New	+$263K	0.01%	528

Other funds holding AERI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

IndexIQ Advisors's AERI Position: Q1 2022 in Review

IndexIQ Advisors opened a new position in Aerie Pharmaceuticals (AERI) in Q1 2022: 42,041 shares worth $383K. The stake represents 0.01% of the portfolio and ranks #890 among its holdings. This is a return to the name: IndexIQ Advisors previously reported a position in AERI as recently as Q4 2020.

IndexIQ Advisors first reported a position in AERI in Q1 2020 and has held it in 5 quarters since. 136 funds tracked by Wall St. Rank hold AERI as of Q1 2022.

IndexIQ Advisors held 42,041 shares of Aerie Pharmaceuticals worth $383K as of Q1 2022.
Aerie Pharmaceuticals was a new IndexIQ Advisors position in Q1 2022.
Aerie Pharmaceuticals made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #890 holding.
IndexIQ Advisors first reported a position in Aerie Pharmaceuticals in Q1 2020 and has held it in 5 quarters since.
136 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.